Feasibility Study of a New Immunoglobulin E (IgE) Assay Method
ConditionAllergy and Immunology
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-99
SponsorUniversity Hospital, Toulouse
About this trial
The main objective is to study the feasibility of a new specific IgE assay using a bioluminescence technique in a pediatric and adult allergic population. For this, we will collect blood, and urine during a blood test scheduled for the follow-up of the patient.
Eligibility criteria
Qualifiers
Males or females 6 months' old or older
positive skin test (s)
and / or IgE specific (s)> 0.1 kUA / L
and / or anamnesis in favor of an allergic reaction of mediated IgE
Disqualifiers
Children younger than 6 months'old
Children's weight less than 10 kg
Pregnant or breastfeeding women
Patients with cystic fibrosis
Trial design
Treatments tested in this trial
- collection of blood and urine
Treatment groups
1,376 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov